( 2020 ) reported that ShTSP-2 conferred a highly significant protection against heterologous challenge ( S. mansoni ) model of infection.
← all excerpts
A comprehensive and critical overview of schistosomiasis vaccine candidates.
1
—
—
( 2020 ) reported that ShTSP-2 conferred a highly significant protection against heterologous challenge ( S. mansoni ) model of infection.